Medy-Tox Inc. (KOSDAQ: 086900)

Medy-Tox Revenue

Medy-Tox had revenue of 65.01B KRW in the quarter ending June 30, 2024, with 25.52% growth. This brings the company's revenue in the last twelve months to 246.25B, up 23.10% year-over-year. In the year 2023, Medy-Tox had annual revenue of 221.12B with 13.34% growth.

• Revenue (ttm): 246.25B
• Revenue Growth: +23.10%
• P/S Ratio: 3.43
• Revenue / Employee: 350.29M
• Employees: 703
• Market Cap: 829.97B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	221.12B	26.02B	13.34%
Dec 31, 2022	195.10B	10.23B	5.53%
Dec 31, 2021	184.87B	44.04B	31.27%
Dec 31, 2020	140.83B	-65.07B	-31.60%
Dec 31, 2019	205.90B	455.34M	0.22%